Brief: Arch Biopartners Files New Patent Application For Novel Antibody Candidates Targeting DPEP-1 Mediated Organ Inflammation
10/06/2021 12:27
June 10 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS FILES NEW PATENT APPLICATION FOR NOVEL
ANTIBODY
CANDIDATES TARGETING DPEP-1 MEDIATED ORGAN INFLAMMATION
Source text for Eikon: ID:nGNXDrdqk
Further company coverage: ARCH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide